- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
JCR Pharmaceuticals (4552)
Track today's live JCR Pharmaceuticals (4552) share price, performance and key data on this page with our current Tokyo:4552 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the JCR Pharmaceuticals share price on the Tokyo exchange. Use the dropdown to switch exchange for the 4552 share price, head to our technical summary section, which provides analysis on JCR Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the JCR Pharmaceuticals (4552) stock price today with other investors in the JCR Pharmaceuticals TYO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TYO:4552 share price (ISIN: JP3701000006) to enhance your trading decisions with our free investment tools and resources.
What Is the JCR Pharmaceuticals Share Price Today?
The JCR Pharmaceuticals share price today is 525.0.
What Is the Stock Symbol for JCR Pharmaceuticals
The stock symbol (or 'ticker') for JCR Pharmaceuticals Co Ltd is "4552."
What Stock Exchange Does JCR Pharmaceuticals Trade On?
JCR Pharmaceuticals Co Ltd is listed and trades on the Tokyo stock exchange.
Is JCR Pharmaceuticals a Good Stock to Buy?
Determining whether JCR Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TYO:4552 share price (ISIN: JP3701000006) to enhance your trading decisions with our free investment tools and resources.
What Is the JCR Pharmaceuticals Share Price Today?
The JCR Pharmaceuticals share price today is 525.0.
What Is the Stock Symbol for JCR Pharmaceuticals
The stock symbol (or 'ticker') for JCR Pharmaceuticals Co Ltd is "4552."
What Stock Exchange Does JCR Pharmaceuticals Trade On?
JCR Pharmaceuticals Co Ltd is listed and trades on the Tokyo stock exchange.
Is JCR Pharmaceuticals a Good Stock to Buy?
Determining whether JCR Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Tokyo
Currency in JPY
525.0
+27.0(+5.42%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
502.0
531.0
52 wk Range
444.0
824.0
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
502.0531.0
52 wk Range
444.0824.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4552 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
618.3
Upside
+17.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
5 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 618.3
(+17.78% Upside)
Earnings
Latest Release
30/07/2026
EPS / Forecast
-15.64 / --
Revenue / Forecast
9.7B / 10.4B
Compare 4552 to Peers and Sector
Metrics to compare | 4552 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4552PeersSector | |
|---|---|---|---|---|
P/E Ratio | 78.7x | 13.9x | −0.3x | |
PEG Ratio | 0.68 | 0.19 | 0.00 | |
Price/Book | 1.5x | 1.0x | 2.6x | |
Price / LTM Sales | 1.6x | 1.5x | 3.1x | |
Upside (Analyst Target) | 2.5% | 17.6% | 49.0% | |
Fair Value Upside | Unlock | 12.5% | 6.3% | Unlock |
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, biopharmaceuticals, medical equipment, regenerative medicines, and drug substances in Japan. The comany offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was founded in 1975 and is based in Ashiya, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the JCR Pharmaceuticals (Tokyo: 4552) Share Price Today?
The JCR Pharmaceuticals stock price today is 525.0 JPY.
What Stock Exchange Does JCR Pharmaceuticals (4552) Trade On?
JCR Pharmaceuticals is listed and trades on the Tokyo Stock Exchange.
What Is the Ticker (Stock Symbol) for JCR Pharmaceuticals?
The stock symbol (also called a 'ticker') for JCR Pharmaceuticals is "4552."
Does JCR Pharmaceuticals Pay Dividends? What’s The Current 4552 Dividend Yield?
Yes, 4552 Pays Dividends to its Shareholders. The current JCR Pharmaceuticals dividend yield is 4.02%.
What Is the Current JCR Pharmaceuticals Market Capitalisation?
As of today, JCR Pharmaceuticals (Tokyo: 4552) market cap is 60.77B JPY.
What Is JCR Pharmaceuticals's (4552) Earnings Per Share (TTM)?
The JCR Pharmaceuticals EPS is currently 6.7 (Trailing Twelve Months).
When Is the Next JCR Pharmaceuticals Earnings Date?
JCR Pharmaceuticals's next earnings report will be released on 28/10/2026.
Is 4552 a Buy or Sell From a Technical Analyst Perspective?
Based on today's JCR Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for 4552 stock is Strong Buy.
How Many Times Has JCR Pharmaceuticals Stock Split?
JCR Pharmaceuticals has split 1 times. (See the 4552 stock split history page for full effective split date and price information.)
How Many Employees Does JCR Pharmaceuticals Have?
JCR Pharmaceuticals has 985 employees, based on their latest Companies House report.
What is the current trading status of JCR Pharmaceuticals (Tokyo: 4552)?
As of 18/08/2026, JCR Pharmaceuticals (4552) is trading at a share price of 525.0 JPY, with a previous close of 498.0 JPY. The stock has fluctuated within a day range of 502.0 JPY to 531.0 JPY, while its 52-week range spans from 444.0 JPY to 824.0 JPY.
What Is JCR Pharmaceuticals (4552) Price Target According to Analysts?
The average 12-month price target for JCR Pharmaceuticals is 618.3 JPY, with a high estimate of 900 JPY and a low estimate of 500 JPY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +17.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.